Recruitment Status: Not yet recruiting
Estimated Study Start Date: September 2023
Estimated Study Completion Date: September 2028
Each participant will be taking ambroxol [or placebo] for two years, and it is estimated that it will take two years to recruit 330 PwPs.
Ambroxol to Slow Progression in Parkinson Disease (ASPro-PD):
why would they take so long to complete?? 2028??
"Each participant will be taking ambroxol [or placebo] for two years, and it is estimated that it will take two years to recruit 330 PwPs."
Plus maybe one year to analyze the data and publish the results?
I'm going to register for this one if I can. I have faith in the team, its got a 6 month open label phase so even the placebo group gets to try it, and big pharma is out of the loop so if it proves to be a usable modality the price will not be hiked up. For those that haven't seen the update, I've attached below. Dare we hope?
bloody ridiculous that we have to wait 3 years for a drug that has been available over the counter for years and which phase 2 trials have confirmed have no side effects and help slow PD.
It is frustrating, but the doses are much bigger than the previous prescribed use. Hopefully things will move faster if they can recruit quickly. I feel your pain though. Time is brain for those of us waiting and trying to keep in a holding pattern.
A question to Ambroxol users
Why consider Ambroxol for PD?
The Correct Curcumin for Used in "The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study" Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
squalamine which has been shown to remove alpha synuclein from the gut and is now in clinical trials for the certain symptoms associated wit
